Why was the Criteria document developed?
Intravenous immunoglobulin (IVIg) is a life-saving therapy in appropriately selected patients and clinical settings. The new Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia (the Criteria) was developed to ensure IVIg use remains consistent with the available evidence and for the treatment of patients who are likely to derive a genuine health benefit. The Criteria updates recommendations on the use and supply of IVIg developed in 2000.
